Cell production and automation

SCS is at the forefront of bio-manufacturing processes for the efficient, automated and large scale production and manipulation of stem cells.

With a particular focus on human and rodent neural, adipose, osteoblast and muscle stem cells, SCS provides the pharmaceutical research industry with simplified and fast access to these breakthrough technologies. This may be achieved by either technology transfer, enabling research teams to manufacture and control the cells in house or alternatively, SCS can culture and deliver stem or differentiated cells to research labs in a just- in-time fashion.

SCS provides researchers with an essentially unlimited supply of human physiologically relevant cells on which to conduct their discovery research, enabling assay development, screening, and the follow-up optimisation assays of new pharmacologically active compounds to be conducted on identical cells over extended periods of time.

Our advances in media and culture techniques allow the stem cells to be produced in standard adherent
T-flask cultures, either manually or using automated platforms. The cultures are feeder and serum free adding further to the consistency of cell phenotype necessary for greater success in modern drug discovery.

For two years, SCS has operated our fully equipped cell culture facility in Cambridge UK which incorporates state of the art automation for cell culture, the CompacT SelecT™ from The Automation Partnership together with cell analysis equipment.

NEW – Our latest service is to offer automated contract neural stem cell derivation.

We offer a flexible approach with services customised to individual project requirements

• Provision of stem cell lines and technology transfer

• Supply of stem or differentiated cells on a daily, weekly, monthly basis

• Services available for small to large scale cell cultures (from 10 to 109 cells)

• Standard or customer provided quality control specifications

• Variety of delivery formats available: assay ready plates, vials; live or frozen cells, etc

• T-flask automation protocol development

SCS proprietary cells available – click here for details

• Embryonic or tissue specific stem cell lines

• Differentiated cells (neurons, astrocytes, adipocytes, osteoblasts)

• Generation of stable recombinant stem cell lines using SCS proprietary cell lineage selection and
  marker technology

• Conversion to SC Proven® or customer specified serum-free media

 

 

 

Robotic delivery to incubator

Dispense cells to plate wells

Pooling cells

Plate incubator